Launched in 2020, RUSH’s breast cancer risk assessment program systematically assesses the risk of breast cancer, offering patients who qualify opportunities for supplemental screening in order to improve their breast cancer detection rate.

Mia Levy, MD, PhD, the director of the Cancer Center at RUSH University Medical Center and the system vice president for cancer services at the RUSH University System for Health, joins the podcast to talk about RUSH’s program, what she sees as the evolution for this type of learning system at RUSH, and what are some of the early findings--and questions--that have come up thus far.

“We want to learn from the experiences of every patient who’s coming through our breast cancer screening program--not just the patients who are participating in clinical trials. In this way, we are optimizing our workflows and data collection to evaluate the outcomes of the program and continuously improve on our screening guidelines and our workflows in order to optimize the best outcomes for our patients.”

CME credit link: https://cmetracker.net/RUSH/Publisher?page=pubOpen#/EventID/482640